PTHS

Pelthos Therapeutics Inc.
PTHS

Overview Fund Activity

5 hedge funds and large institutions have $59.6K invested in Pelthos Therapeutics Inc. in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.07%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
2
Reduced
–
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
APP
1
Avantax Planning Partners
Iowa
$33.5K
2
TSS
2
Two Sigma Securities
New York
$18.5K
3
Wealth Enhancement Advisory Services
3
Wealth Enhancement Advisory Services
Minnesota
$7.39K
4
TRCT
4
Tower Research Capital (TRC)
New York
$184
5
Bank of America
5
Bank of America
North Carolina
$8

Top Sellers

1
AFM
1
Anson Funds Management
Texas
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$0
3
UBS Group
3
UBS Group
Switzerland
$0
Name Market Value Shares Shares
Change 		Shares
Change %
APP
1
Avantax Planning Partners
Iowa
$33.5K 47,205 +47,205 New
TSS
2
Two Sigma Securities
New York
$18.5K 26,061 +26,061 New
Wealth Enhancement Advisory Services
3
Wealth Enhancement Advisory Services
Minnesota
$7.39K 10,400 +10,400 New
TRCT
4
Tower Research Capital (TRC)
New York
$184 259 +253 +4,217%
Bank of America
5
Bank of America
North Carolina
$8 11 +2 +22%
AFM
6
Anson Funds Management
Texas
– – -201,030 Closed
Citadel Advisors
7
Citadel Advisors
Florida
– – -18,714 Closed
UBS Group
8
UBS Group
Switzerland
– – -186 Closed
CFGS
9
Concourse Financial Group Securities
Alabama
– – – –